Cargando…

LDL Cholesterol Variability Impacts the Prognosis of Patients with Chronic Ischemic Heart Disease: A Real-World Italian Experience

Epidemiologic, genetic, and clinical intervention studies have indisputably shown that low-density lipoprotein cholesterol (LDL-C) is causal in the development of atherosclerotic cardiovascular disease (ASCVD). However, LDL-C variability could be related to increased ASCVD risk in patients already t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faggiano, Pompilio, Ruscica, Massimiliano, Bettari, Sara, Cherubini, Antonella, Carugo, Stefano, Corsini, Alberto, Barbati, Giulia, Di Lenarda, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573184/ https://www.ncbi.nlm.nih.gov/pubmed/37834875 http://dx.doi.org/10.3390/jcm12196231

Ejemplares similares

The Role of High-Density Lipoprotein Cholesterol in 2022
por: Sirtori, Cesare R., et al.
Publicado: (2022)

Global Cardiovascular Risk Profile of Italian Medical Students Assessed by a QR Code Survey. Data from UNIMI HEART SURVEY: Does Studying Medicine Hurt?
por: Faggiano, Andrea, et al.
Publicado: (2021)

Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

PCSK9 Inhibition and Risk of Diabetes: Should We Worry?
por: Carugo, Stefano, et al.
Publicado: (2022)

ApoB and Non‐HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk
por: Johannesen, Camilla D. L., et al.
Publicado: (2022)

HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study
por: Papotti, Bianca, et al.
Publicado: (2021)

Prognostic parameters of in‐hospital mortality in COVID‐19 patients—An Italian experience
por: Ruscica, Massimiliano, et al.
Publicado: (2021)

Cardiovascular Calcification as a Marker of Increased Cardiovascular Risk and a Surrogate for Subclinical Atherosclerosis: Role of Echocardiography
por: Faggiano, Andrea, et al.
Publicado: (2021)

Aortic Valve Stenosis and Cancer: Problems of Management
por: Santangelo, Gloria, et al.
Publicado: (2023)

HDL‐mediated reduction of cholesterol content inhibits the proliferation of prostate cancer cells induced by LDL: Role of ABCA1 and proteasome inhibition
por: Ossoli, Alice, et al.
Publicado: (2022)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter setting in Germany
por: Makhmudova, U., et al.
Publicado: (2023)

Targeting LDL Cholesterol With LNA
por: Krieg, Arthur M
Publicado: (2012)

Cellular itinerary of LDL cholesterol
por: Vance, Jean E.
Publicado: (2022)

Friedewald’s equation for calculating LDL-cholesterol: Is it the time to say “Goodbye” and adopt direct LDL cholesterol methods?
por: Khan, Sikandar Hayat, et al.
Publicado: (2019)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

Prognostic significance of visit-to-visit variability, and maximum and minimum LDL cholesterol in diabetes mellitus
por: Sheng, Chang-Sheng, et al.
Publicado: (2022)

Updates in Small Interfering RNA for the Treatment of Dyslipidemias
por: Carugo, S., et al.
Publicado: (2023)

Secondary prevention and follow-up of patients with ACS and not-at-target LDL: An Italian real-world retro-prospective analysis by the inertia group
por: Del Pinto, Maurizio, et al.
Publicado: (2023)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Echocardiographic markers of inducible myocardial ischemia at baseline evaluation preparatory to exercise stress echocardiography
por: Cherubini, Antonella, et al.
Publicado: (2016)

Role of lipoprotein(a) in plaque progression
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid
por: Ferri, Nicola, et al.
Publicado: (2023)

A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia
por: De Castro-Orós, Isabel, et al.
Publicado: (2014)

The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration
por: Atamanalp, S. Selcuk, et al.
Publicado: (2013)

Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
por: Higashi, Yukihito
Publicado: (2023)

The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management
por: Santangelo, Gloria, et al.
Publicado: (2023)

LDL cholesterol estimation in patients with the metabolic syndrome
por: Gazi, Irene, et al.
Publicado: (2006)

LDL Cholesterol and Dysglycemia: an Intriguing Physiological Relationship
por: Merino, Jordi, et al.
Publicado: (2020)

LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Addressing dyslipidemic risk beyond LDL-cholesterol
por: Tall, Alan R., et al.
Publicado: (2022)

Does treatment assignment influence the prognosis of patients with symptomatic severe aortic stenosis?
por: Cioffi, Giovanni, et al.
Publicado: (2015)

Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study
por: Hansen, Malene Kærslund, et al.
Publicado: (2023)

Comparison of calculated LDL-cholesterol using the Friedewald formula and de Cordova formula with a directly measured LDL-cholesterol in Nepalese population
por: Pradhan, Santosh, et al.
Publicado: (2020)

Joint effect of visit-to-visit variability in LDL-cholesterol, HDL-cholesterol and HbA1c on cardiovascular and total mortality in patients with diabetes
por: He, Panpan, et al.
Publicado: (2022)

Proteomics and Lipidomics to unveil the contribution of PCSK9 beyond cholesterol lowering: a narrative review
por: Gianazza, Erica, et al.
Publicado: (2023)

Validation of the Friedewald Equation for Evaluation of Plasma LDL-Cholesterol
por: Fukuyama, Naoto, et al.
Publicado: (2008)

Impact of oxLDL on Cholesterol-Rich Membrane Rafts
por: Levitan, Irena, et al.
Publicado: (2011)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Postprandial decrease in LDL-cholesterol in men with metabolic syndrome
por: Skoczyńska, Anna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l01fqmo8jevug56sbi1hvan0qh